5PSQ-119 A new pharmaceutical care programme for COVID-19 patients treated with Paxlovid®: Implementation and safety outcomes reported | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 5: Patient safety and quality assurance

5PSQ-119 A new pharmaceutical care programme for COVID-19 patients treated with Paxlovid^®: Implementation and safety outcomes reported

Free

Online download statistics by month:

Online download statistics by month: March 2023 to September 2024

	Abstract	Full	Pdf
Mar 2023	22	0	3
Apr 2023	46	0	3
May 2023	35	0	7
Jun 2023	15	0	1
Jul 2023	18	0	4
Aug 2023	13	0	0
Sep 2023	21	0	3
Oct 2023	34	0	5
Nov 2023	23	0	2
Dec 2023	14	0	4
Jan 2024	18	0	4
Feb 2024	10	0	2
Mar 2024	17	0	32
Apr 2024	6	0	9
May 2024	14	0	4
Jun 2024	6	0	1
Jul 2024	3	0	3
Aug 2024	1	0	5
Sep 2024	11	0	2
Total	327	0	94